Progyny, Inc. (PGNY) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PGNY Revenue Growth
Revenue Breakdown (FY 2025)
PGNY's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
PGNY Revenue Analysis (2017–2025)
As of May 8, 2026, Progyny, Inc. (PGNY) generated trailing twelve-month (TTM) revenue of $1.29 billion, reflecting modest growth of +1.4% year-over-year. The most recent quarter (Q1 2026) recorded $328.5 million in revenue, up 3.2% sequentially.
Looking at the longer-term picture, PGNY's 5-year compound annual growth rate (CAGR) stands at +30.2%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $1.29 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows PGNY's business is primarily driven by Fertility benefit services revenue (64%), and Pharmacy benefit services revenue (36%). With over half of revenue concentrated in Fertility benefit services revenue, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HIMS (+59.0% YoY), LFST (+16.5% YoY), and GDRX (-1.2% YoY), PGNY has underperformed the peer group in terms of revenue growth. Compare PGNY vs HIMS →
PGNY Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PGNYCurrent | $1.3B | +1.4% | +30.2% | 6.6% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 LFST | $1.4B | +16.5% | +30.4% | 1.8% | |
 GDRX | $797M | -1.2% | +7.7% | 13.4% | |
 CVS | $402.1B | +7.6% | +8.4% | 2.6% | |
 CI | $275.0B | +8.8% | +11.4% | 3.3% |
PGNY Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.29B | +10.4% | $304.5M | 23.6% | $85.3M | 6.6% |
| 2024 | $1.17B | +7.2% | $253.4M | 21.7% | $67.5M | 5.8% |
| 2023 | $1.09B | +38.3% | $238.8M | 21.9% | $62.2M | 5.7% |
| 2022 | $786.9M | +57.2% | $167.3M | 21.3% | $23.3M | 3.0% |
| 2021 | $500.6M | +45.2% | $112.1M | 22.4% | $32.3M | 6.5% |
| 2020 | $344.9M | +50.1% | $70.1M | 20.3% | $8.3M | 2.4% |
| 2019 | $229.7M | +117.9% | $45.5M | 19.8% | $9.7M | 4.2% |
| 2018 | $105.4M | +116.9% | $19.4M | 18.4% | $-3,452,000 | -3.3% |
| 2017 | $48.6M | - | $7.4M | 15.2% | $-11,005,000 | -22.7% |
See PGNY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PGNY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PGNY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPGNY — Frequently Asked Questions
Quick answers to the most common questions about buying PGNY stock.
Is PGNY's revenue growth accelerating or slowing?
PGNY revenue growth slowed to +1.4%, below the 5-year CAGR of +30.2%. TTM revenue is $1.3B. The deceleration marks a shift from historical growth rates.
What is PGNY's long-term revenue growth rate?
Progyny, Inc.'s 5-year revenue CAGR of +30.2% reflects the variable expansion pattern. Current YoY growth of +1.4% is near this long-term average.
How is PGNY's revenue distributed by segment?
PGNY reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.